M
Mark R Anderson
Researcher at Birmingham City Hospital
Publications - 6
Citations - 551
Mark R Anderson is an academic researcher from Birmingham City Hospital. The author has contributed to research in topics: Duodenal-jejunal bypass liner & Dysplasia. The author has an hindex of 3, co-authored 6 publications receiving 479 citations.
Papers
More filters
Journal ArticleDOI
Consensus Statements for Management of Barrett's Dysplasia and Early-Stage Esophageal Adenocarcinoma, Based on a Delphi Process
Cathy Bennett,Nimish Vakil,Jacques J. Bergman,Rebecca Harrison,Robert D. Odze,Michael Vieth,Scott Sanders,Oliver Pech,Gaius Longcroft-Wheaton,Yvonne Romero,John M. Inadomi,Jan Tack,Douglas A. Corley,Hendrik Manner,Susi Green,David Al Dulaimi,Haythem Ali,Bill Allum,Mark R Anderson,Howard Curtis,Gary W. Falk,M. Brian Fennerty,Grant Fullarton,Kausilia K. Krishnadath,Stephen J. Meltzer,David Armstrong,Robert A. Ganz,Gianpaolo Cengia,James J. Going,John R. Goldblum,Charles Gordon,Heike I. Grabsch,Chris Haigh,Michio Hongo,David Johnston,Ricky Forbes-Young,Elaine Kay,Philip Kaye,Toni Lerut,Laurence Lovat,Lars Lundell,Philip Mairs,Tadakuza Shimoda,Stuart J. Spechler,Stephen J. Sontag,Peter Malfertheiner,Iain A. Murray,Manoj Nanji,David N. Poller,Krish Ragunath,Jaroslaw Regula,Renzo Cestari,Neil A. Shepherd,Rajvinder Singh,Hubert J. Stein,Nicholas J. Talley,Jean Paul Galmiche,Tony C.K. Tham,Peter Watson,Lisa Yerian,Massimo Rugge,Thomas W. Rice,John Hart,Stuart Gittens,David Hewin,Juergen Hochberger,Peter J. Kahrilas,Sean L. Preston,Richard E. Sampliner,Prateek Sharma,Robert C. Stuart,Kenneth K. Wang,Irving Waxman,Chris Abley,Duncan Loft,Ian D. Penman,Nicholas J. Shaheen,Amitabh Chak,Gareth Davies,L. J. Dunn,Yngve Falck-Ytter,John deCaestecker,Pradeep Bhandari,Christian Ell,S. Michael Griffin,Stephen Attwood,Hugh Barr,John J.B. Allen,Mark K. Ferguson,Paul Moayyedi,Janusz Jankowski,Janusz Jankowski,Janusz Jankowski +92 more
TL;DR: An international, multidisciplinary, systematic, evidence-based review of different management strategies for patients with Barrett's esophagus and dysplasia or early-stage EA and developed a data-sifting platform and used the Delphi process to create evidence- based consensus statements.
Journal ArticleDOI
Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial
Janusz Jankowski,John de Caestecker,Sharon Love,Sharon Love,Gavin Reilly,Peter Watson,Scott Sanders,Yeng Ang,Yeng Ang,Danielle Morris,Pradeep Bhandari,Claire Brooks,Stephen Attwood,Rebecca Harrison,Hugh Barr,Paul Moayyedi,Krish Ragunath,Bashir Rameh,Grant Fullarton,Grant Fullarton,Art Tucker,Ian D. Penman,Colin Rodgers,James Neale,Cathryn Edwards,Adelyn Wise,Stephen Jones,Nicholas I. Church,Kishor Vaidya,Sherzad Balata,John Todd,Michael Gibbons,David Johnston,Mark R Anderson,Gareth Davies,William Dickey,Andrew Murdock,Graham Turner,Andrew F Goddard,Stephen Gore,Chris Haigh,Timothy Harding,Lucina Jackson,Iain A. Murray,Joy Worthingon,Thomas Lee,Peik Loon Lim,James McLoughlin,Christopher Macdonald,Philip Mairs,David Monk,Sean L. Preston,Stirling Pugh,Howard Smart,A Soliman,Peter Isaacs,David Aldulaimi,Nigel Trudgill,Julian Teare,Abduljalil Benhamida,Andrew I. Bell,Robert Boulton-Jones,Tawfique Daneshmend,Hisaharu Suzuki,Sue Cullen,Rebecca C. Fitzgerald,Rupert Ransford,Mohammad Mesbahur Rahman,Giovanni Domenico Tebala,Michael Hallissey,Carrie Kelly,Tamas Hickish,Ali S. Taha,Johan Rademaker,Mark Whitehead,Sean M. Kelly,Perminder Phull,Naveen Sharma,Ian Perry,Vankatraman Sankara-Raman,Haythem Ali,Iqbal Ansary Khan,Howard Curtis,Martin Wadley,Adam Stone,Sumesh Sukumaran,Andrew Higham,Stephen R. Lewis,Adam Haycock,Bernhard Usselmann,Simon D. Johnston,Tony C.K. Tham,Stewart J Campbell,Andrew C Douds,Jason M. Dunn,Ian Sargeant,Mark Narain,Nick Maynard,Andrew Chilton,Susi Green,Duncan Loft,Bart Decadt,Michael A. Mendall,Mathis Heydtmann,Neil Fisher +104 more
TL;DR: High-dose PPI and aspirin chemoprevention therapy, especially in combination, significantly and safely improved outcomes in patients with Barrett's oesophagus.
Journal ArticleDOI
The United Kingdom's first NHS Endobarrier service for advanced diabesity: 1-year outcomes for all 62 treated patients
Robert E.J. Ryder,Susan P. Irwin,Wyn Burbridge,Hardeep Gandhi,Tahira Bashir,Rachael A Allden,Mordel Wilson,Melanie C. Wyres,Melissa L. Cull,Mahi Yadagiri,John Bleasdale,Edward Fogden,Mark R Anderson,Piya Sen Gupta +13 more
TL;DR: EndoBarriers was highly effective in this setting in patients with advanced diabetes and obesity, suggesting that EndoBarrier treatment in 100 such patients could prevent 8 events of CHD or stroke and save 6 lives over the 10 years.
Journal ArticleDOI
The United Kingdom’s first NHS EndoBarrier service for long-standing poorly controlled type 2 diabetes and obesity: outcomes one year after EndoBarrier removal
Robert E.J. Ryder,Mahi Yadagiri,Wyn Burbridge,Susan P. Irwin,Hardeep Gandhi,Tahira Bashir,Rachael A Allden,Melanie C. Wyres,Melissa L. Cull,John Bleasdale,Edward Fogden,Mark R Anderson,Piya Sen Gupta +12 more
TL;DR: It is demonstrated that EndoBarrier is highly effective in people with long-standing poorly controlled type 2 diabetes and obesity, with maintenance of significant improvement one year after removal in 78% of cases for whom data were available.
Journal ArticleDOI
Maintenance of efficacy after duodenal– jejunal bypass liner explantation in the first NHS EndoBarrier service
Robert E.J. Ryder,Mahi Yadagiri,Susan P. Irwin,Wyn Burbridge,Hardeep Gandhi,Rachael A Allden,John Bleasdale,Edward Fogden,Mark R Anderson,Piya Sen Gupta +9 more
TL;DR: EndoBarrier ®, a 60 cm endoscopically implanted proximal intestinal liner, reduces weight and HbA 1c over 1 year and most patients stated that they would be extremely likely to recommend the service to friends and family, encouraging for wider establishment of NHS EndoBarriers services.